Evidence map›Paper›PMID 38473903›Full record

ArticleInternational journal of molecular sciences2024

Analysis of the

Annamaria Cudini, Caterina Nardella, Emanuele Bellacchio, Alessia Palma, Domenico Vittorio Delfino, Corrado Betterle, Marco Cappa, Alessandra Fierabracci

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Aire Mutations and Autoimmune Diseases.Advances in experimental medicine and biology · 2025
    Review
  2. The Putative Role ofInternational journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Annamaria CudiniBambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
Caterina NardellaBambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
Emanuele BellacchioMolecular Genetics and Functional Genomics, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.ORCID 0000-0002-2757-849X
Alessia PalmaBambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
Domenico Vittorio DelfinoSection of Pharmacology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy.ORCID 0000-0003-1792-9468
Corrado BetterlePadua University, 35128 Padua, Italy.
Marco CappaResearch Unit for Innovative Therapies in Endocrinopathies, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
Alessandra FierabracciBambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.ORCID 0000-0003-3078-9754
Bambino Gesù Children's Hospital · ITUniversity of Padua · ITUniversity of Perugia · IT

Funding

Italian Ministry of Health Current Research Funds
6 · The paper itself

Abstract

Autoimmune polyglandular syndromes (APS) are classified into four main categories, APS1-APS4. APS1 is caused by

Indexed as

Polyendocrinopathies, AutoimmuneHumansMutationPolymorphism, Single NucleotidePromoter Regions, GeneticSyndromeAIREAIRE gene promoterautoimmune etiopathogenesisautoimmune polyglandular syndromepolymorphismssequencing

Identifiers

PMID38473903
PMCPMC10932416
OpenAlexW4392166107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.